MYC and hepatocellular carcinoma: In parallel, our analysis of the GSE97098 dataset, containing IC50 values for cabozantinib across HCC cell lines, classified cell lines into resistant (IC50 ≥ 18 μM) and sensitive groups, revealing significantly elevated c-Myc expression in resistant cell lines (FigS4 A).